home All News open_in_new Full Article

De Valladolid a Estados Unidos: Amadix prevé comercializar su test de detección del cáncer en el mercado americano en 2028

La CEO de la compañía, Rocío Arroyo, explica a EL ESPAÑOL-Invertia que prevén tener la aprobación de la FDA en 2027. Más información: Amadix obtiene un préstamo de 15 millones del BEI para desarrollar productos de detección del cáncer


today 3 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics


ID: 3579416063
Add Watch Country

arrow_drop_down